All News

More Americans have received at least 1 dose of a coronavirus disease 2019 (COVID-19) vaccine than have tested positive for the virus; Biden administration funds mass production of a rapid over-the-counter COVID-19 test; breast cancer surpasses lung cancer as most common cancer worldwide.

Individuals with serious mental illness have a greater risk of acquiring HIV compared with the general population and could therefore benefit from preexposure prophylaxis (PrEP) services in the community.

Robin Gelburd, JD, president of FAIR Health, discusses the massive jump in telehealth claims from November 2019 to November 2020.

Welfare recipients who were unable to meet their rent or mortgage payments were more likely to have impaired sleep duration and sleep quality, with those forced to move exhibiting more severe impairment.

Among patients with episodic migraine in whom 2 to 4 preventives were not useful, erenumab was efficacious in improving functional outcomes after 12 weeks of treatment.

With the ongoing coronavirus disease 2019 pandemic, a rising number of uninsured Americans, and a new Democratic president and Senate majority, 2021 is shaping up to be a dynamic year for health care policy.

CDC mandate requiring masks on most forms of public transportation to go into effect today; FDA will extend its review period on a possible new Alzheimer disease drug; HHS will delay the start date of a Trump administration drug pricing rebate rule.

An apparent first case of psoriatic arthritis triggered by coronavirus disease 2019 (COVID-19) was reported in a genetically predisposed patient.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Recent results with adavosertib in ovarian cancer could signal future positive results, given the number of trials using the targeted therapy with the PARP inhibitor olaparib.

A 9% year-over-year increase was observed in the number of US Medicare beneficiaries who enrolled in a Medicare Advantage health plan in 2020, with the increase in enrollment influenced by the coronavirus disease 2019 pandemic and its related effects.

Shortening a traditional 45-day course of radiation therapy to 5 days of stereotactic body radiotherapy for patients with advanced, high-risk prostate cancer is safe and effective, a study from UCLA Jonsson Comprehensive Cancer Center found.

Researchers find that a patient with depressive symptoms and cognitive impairment who did not respond to prior antidepressant medication showed marked improvement through continuous positive airway pressure (CPAP) therapy after being diagnosed with underlying severe obstructive sleep apnea.

A study found that chronic obstructive pulmonary disease (COPD) and asthma were not risk factors for ICU admission or death as a result of SARS-CoV-2 infection.

As up to 1 in 3 patients with pulmonary arterial hypertension have unknown explanations for their disease and its pathobiology, a team of researchers is exploring the genetic architecture of pulmonary arterial hypertension (PAH).

The findings suggest that this new categorization of cognitive deficits in multiple sclerosis may support clinicians in treatment choices and help tailor cognitive rehabilitation strategies, the authors said.

An engineered lentivirus was created to avoid some of the drawbacks associated with current gene therapy vectors for sickle cell disease (SCD) and beta-thalassemia.

The authors said this study included more up-to-date definitions of diagnosing pulmonary arterial hypertension (PAH), which is an increasing factor in deaths from systemic sclerosis (SSc).

The novel, first-in-class, small molecule prompted high rates of clinical response and molecular remission in patients with oligoblastic acute myeloid leukemia (AML).

Study results published in PLoS One strongly suggest machine learning can be an effective approach to identify patients who should receive a diagnostic biochemical test to screen for acute hepatic porphyria.

A 4-biomarker panel can help ensure rheumatoid arthritis (RA) is accurately diagnosed, according to study results published in Arthritis Research & Therapy.

Johnson & Johnson, Novavax, release positive results from phase 3 trials on their respective coronavirus disease 2019 (COVID-19) vaccines; report indicates undercounted nursing home deaths in New York; experts push for improved mask practices.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A recent survey found that patients experienced relief of certain motor and nonmotor symptoms of Parkinson disease from using cannabis.

The intersection of climate change and negative impacts on health were brought into sharp focus this week with executive orders from President Biden, a move by General Motors (GM) to stop making some gasoline-powered cars, and top global cardiology organizations calling for urgent action on air pollution.

Treatment optimization for heart failure with reduced ejection fraction is the focus of the American College of Cardiology’s 2021 update to its 2017 Expert Consensus Decision Pathway on managing patients with the condition.

Patients with symptomatic acute hepatic porphyria were found to be at greater risk of accessing long-term sick leave and disability pension compared with the general population, but were not shown to be at an increased overall risk of premature death.

The Biden administration will reopen the health exchanges created by the Affordable Care Act (ACA); direct HHS and other agencies to reexamine other health policies, including Medicaid work requirements; and reverse the so-called global gag rule while affirming support for reproductive health.

Results of a case-control study show metformin use may protect against the development of age-related macular degeneration (AMD) in adults 55 years and older, and the association is dose-dependent, with the greatest benefit at low to moderate doses.

Rates of coronavirus disease 2019 (COVID-19) cases decline in 41 states; Aetna to cover medically necessary breast augmentations for transgender individuals; Oklahoma seeks to return $2 million worth of hydroxychloroquine.